Form 4: Boston Scientific EVP, Global Operations, John Bradley Sorenson, Reports Stock Transactions
SEC Form 4 Filing
John Bradley Sorenson, EVP, Global Operations at Boston Scientific, reports the acquisition and disposal of common stock and restricted stock units on May 2, 2024.
Summary
- On May 2, 2024, John Bradley Sorenson, EVP, Global Operations at Boston Scientific, reported transactions involving Boston Scientific common stock and restricted stock units.
- Sorenson acquired 4,203 shares of common stock upon the vesting of restricted stock units.
- Simultaneously, Sorenson disposed of 1,917 shares of common stock to cover tax obligations at a price of $72.03 per share.
- Following these transactions, Sorenson directly owns 52,924 shares of Boston Scientific common stock and 8,408 restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine executive stock transactions related to compensation. It doesn't indicate any particularly positive or negative sentiment.
Future Outlook
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors to gauge management's sentiment and align interests.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they involve a relatively small number of shares compared to the company's total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/02/2023 | First anniversary of the date of grant for restricted stock units. |
| 05/02/2024 | Date of stock transactions: acquisition of 4,203 shares via restricted stock units and disposal of 1,917 shares for tax obligations. |
| 05/02/2026 | Expiration date of the restricted stock units. |
| 05/06/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.